155
Participants
Start Date
December 7, 2018
Primary Completion Date
September 7, 2023
Study Completion Date
September 7, 2023
Depot medroxyprogesterone acetate (DMPA)
Depot medroxyprogesterone acetate (DMPA) will be dispensed from the Grady Pharmacy Service and will be administered every 12 weeks at the standard dose of 150 mg Intramuscular injection, beginning from week 3 of study enrollment and repeated every 13 weeks
Etonogestrel implant (Eng-Implant)
A standard Nexplanon rod Implant that is a subdermal implant in the arm. This will be placed at study week 3 by Dr. Haddad or a trained clinician. It contains Etonogestrel 68mg.
Levonorgestrel IUD (Lng-IUD)
The Levonorgestrel Intrauterine Device (Lng-IUD) (Mirena or copper) will be placed at study week 3 by Dr. Haddad or a trained clinician.
Grady Health System, Atlanta
The Emory Clinic, Bldg A., 2nd Floor, 1365 Clifton Road, NE, Atlanta
Atlanta Women's Center, Atlanta
National Institutes of Health (NIH)
NIH
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Emory University
OTHER